Results 151 to 160 of about 60,915 (280)

Increased Risk for Liver Disease in Patients With Chronic Hepatitis B Virus Infection and Low‐Level Viraemia

Alimentary Pharmacology &Therapeutics, Volume 63, Issue 12, Page 1626-1634, June 2026.
We used an administrative claims dataset to evaluate the relationship between hepatitis B virus (HBV) low‐level viraemia and subsequent liver‐related outcomes in patients with chronic HBV. We found that individuals with HBV low‐level viraemia have an increased risk for liver‐related events (i.e., cirrhosis, decompensation, and hepatocellular carcinoma)
Paul Y. Kwo, Laura E. Telep, Lai San Hong, Ching Yi Chuo, Betty Chiang, Sarjita D. Naik, Catherine T. Frenette, Amanda W. Singer, Anand P. Chokkalingam, Robert J. Wong, Leland J. Yee, Camilla S. Graham   +11 more
wiley   +1 more source

Expression of HBsAg and HBsAg in liver tissue, correlation with disease activity

, 1992
The pattems of Hepatitis B surface antigen (HBsAg) and Hepatitis B core antigen (HBcAg) expression were studied in liver biopsies taken from 41 patients with chronic HBV disease. Immunohistochemical methods were used on deparaffinized sections for the identification of HBsAg and HBcAg in liver tissue. lkenty-one of the 41 cases (5 1.2%) were classified
Nakopoulou, Lydia, Adraskelas, N., Stefanak, K., Zacharoulis, D., Hadziyanni, St.   +4 more
openaire   +1 more source

Risk Stratification of Chronic Kidney Disease in Adults Using Noninvasive Fibrosis Tests Based on the American Diabetes Association Algorithm

Diabetes, Obesity and Metabolism, Volume 28, Issue 6, Page 5240-5251, June 2026.
ABSTRACT Aims Although the American Diabetes Association (ADA) recently established a diagnostic algorithm for the early detection of liver fibrosis among high‐risk individuals, its implications for chronic kidney disease (CKD) risk stratification remain unclear.
Chan‐Young Jung, Hye Won Lee, Jung Il Lee, Han Ah Lee, Seung Up Kim   +4 more
wiley   +1 more source

Incidence and Characteristics of HBV Reactivation‐Related Events Following HBsAg Seroclearance: Long‐Term Follow‐up of a Population‐Based Cohort in Japan

Hepatology Research, Volume 56, Issue 6, Page 944-955, June 2026.
In a population‐based cohort in Japan, HBV reactivation‐related events were observed after HBsAg seroclearance, including one virologically confirmed hepatic flare occurring spontaneously without chemotherapy or immunosuppression. These findings indicate that HBsAg seroclearance does not always represent complete viral eradication, supporting the need ...
Kazumi Yamasaki, Satoshi Shirahama, Takahiro Yasaka, Shota Yamaguchi, Masashi Mizokami, Junko Tanaka, Hiroaki Okamoto, Hiroshi Yatsuhashi   +7 more
wiley   +1 more source

Hepatitis B Virus Reactivation Risk With IL-17, IL-23/IL-12, or JAK Inhibitors: A Systematic Review and Meta-Analysis. [PDF]

Liver Int
Alhalabi M, Alshiekh HA.
europepmc   +1 more source

Toward a Functional Cure for Chronic Hepatitis B: Current Landscape and Future Directions in Japan

Hepatology Research, Volume 56, Issue 6, Page 903-913, June 2026.
Hepatitis B is a viral liver infection that can become chronic, increasing the risk of developing liver cancer and liver failure. Because current treatments rarely cure these problems, researchers are now focusing on a functional cure in which the virus becomes undetectable in blood and stays that way, even after the treatment ends.
Yutaka Handa, Ethan Yichen Lee, Yasuhito Tanaka   +2 more
wiley   +1 more source

Performance evaluation of the Access HBsAg and Access HBsAg confirmatory assays on the DxI 9000 Access immunoassay analyzer

International audienceIntroductionThis study evaluated the clinical and analytical performances of the Access HBsAg and the Access HBsAg Confirmatory assays on the DxI 9000 Access Immunoassay Analyzer (Beckman Coulter, Inc.).Materials and ...
Stephanie Bord, Roulet, Vanessa, Françoise Le Boulaire, Isabelle Voisin, Yves-Edouard Herpe, Visseaux, Benoit, Jérémie Gautier, Sandrine Gréaume, Plantier, Jean-Christophe, Bord, Stephanie, Vincent, Claire, Etienne Brochot, Marc Turini, Brochot, Etienne, Le Boulaire, Françoise, Gautier, Jérémie, Voisin, Isabelle, Hey, Juliane, Vanessa Roulet, Jean-Christophe Plantier, Claire Vincent, Veronique Lemée, Turini, Marc, Lemée, Veronique, Coignard, Catherine, Herpe, Yves-Edouard, Gréaume, Sandrine, Catherine Coignard, Juliane Hey, Benoit Visseaux   +29 more
core   +1 more source

Real‐world use of second‐generation integrase strand transfer inhibitors (INSTI) as switch therapy in the prospective ANRS‐CO3‐AquiVIH‐NA cohort

HIV Medicine, Volume 27, Issue 6, Page 965-978, June 2026.
Abstract Objectives To characterize real‐world treatment switching in France to bictegravir (BIC or B) or dolutegravir (DTG)‐based regimens with a focus on treatment persistence, effectiveness (HIV‐1 RNA ≤50 copies/ml) and particular attention to the prevalence and incidence of comorbidities. Methods People living with HIV from the prospective ANRS‐CO3‐
O. Leleux, A. Peyrouny‐Mazeau, A. Perrier, M. Hessamfar, G. Le Moal, D. Neau, L. Alleman, C. Cazanave, E. Lazaro, P. Duffau, A. Riché, Y. Gérard, G. Barrière, S. Reigadas, M.‐A. Vandenhende, F. Bonnet   +15 more
wiley   +1 more source

Seroprevalence of hepatitis B Surface antigen among apparently healthy primary school pupils inBatagarawa Local Government area of Katsina State, Nigeria

Nigerian Journal of Paediatrics
Introduction: Hepatitis B virus infection is a major public health problem worldwide. It is more infectious and more in Nigeria than the Human Immunodeficiency Virus (HIV).
Habibu B, Belonwu R, Ibrahim M
doaj  

Beyond viral suppression: combining PEG-interferon with novel immunotherapies for functional cure of chronic hepatitis B. [PDF]

Front Cell Infect Microbiol
Wang Q, Deng W, Wang S, Cao W, Li X, Zhang Z, Xie Y, Xing H, Li M.   +8 more
europepmc   +1 more source